APA

Daenen S., van der Holt B., Dekker A. W., Willemze R., Rijneveld A. W., Biemond B. J., Muus P., van de Loosdrecht A. A., Schouten H. C., van Marwijk Kooy M., Breems D. A., Demuynck H., Maertens J., Wijermans P. W., Wittebol S., de Klerk E. W. & Cornelissen J. J. (20121009). Intensive chemotherapy to improve outcome in patients with acute lymphoblastic leukemia over the age of 40: a phase II study for efficacy and feasibility by HOVON. : Leukemia.

Chicago

Daenen S, van der Holt B, Dekker A W, Willemze R, Rijneveld A W, Biemond B J, Muus P, van de Loosdrecht A A, Schouten H C, van Marwijk Kooy M, Breems D A, Demuynck H, Maertens J, Wijermans P W, Wittebol S, de Klerk E W and Cornelissen J J. 20121009. Intensive chemotherapy to improve outcome in patients with acute lymphoblastic leukemia over the age of 40: a phase II study for efficacy and feasibility by HOVON. : Leukemia.

Harvard

Daenen S., van der Holt B., Dekker A. W., Willemze R., Rijneveld A. W., Biemond B. J., Muus P., van de Loosdrecht A. A., Schouten H. C., van Marwijk Kooy M., Breems D. A., Demuynck H., Maertens J., Wijermans P. W., Wittebol S., de Klerk E. W. and Cornelissen J. J. (20121009). Intensive chemotherapy to improve outcome in patients with acute lymphoblastic leukemia over the age of 40: a phase II study for efficacy and feasibility by HOVON. : Leukemia.

MLA

Daenen S, van der Holt B, Dekker A W, Willemze R, Rijneveld A W, Biemond B J, Muus P, van de Loosdrecht A A, Schouten H C, van Marwijk Kooy M, Breems D A, Demuynck H, Maertens J, Wijermans P W, Wittebol S, de Klerk E W and Cornelissen J J. Intensive chemotherapy to improve outcome in patients with acute lymphoblastic leukemia over the age of 40: a phase II study for efficacy and feasibility by HOVON. : Leukemia. 20121009.